Sagar Sengupta

3.6k total citations
60 papers, 2.9k citations indexed

About

Sagar Sengupta is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sagar Sengupta has authored 60 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 27 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Sagar Sengupta's work include DNA Repair Mechanisms (28 papers), Cancer-related Molecular Pathways (21 papers) and Genomics and Chromatin Dynamics (12 papers). Sagar Sengupta is often cited by papers focused on DNA Repair Mechanisms (28 papers), Cancer-related Molecular Pathways (21 papers) and Genomics and Chromatin Dynamics (12 papers). Sagar Sengupta collaborates with scholars based in India, United States and France. Sagar Sengupta's co-authors include Curtis C. Harris, Bohdan Wasylyk, Rémy Pedeux, Shweta Tikoo, Steven P. Linke, Vivek Tripathi, Susan H. Garfield, Ana I. Robles, Lorne J. Hofseth and Makoto Nagashima and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Sagar Sengupta

60 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sagar Sengupta India 27 2.2k 1.0k 574 237 230 60 2.9k
Denis Biard France 31 2.5k 1.2× 1.2k 1.1× 443 0.8× 250 1.1× 227 1.0× 73 3.1k
Maja Tomičić Germany 30 1.9k 0.9× 783 0.8× 614 1.1× 235 1.0× 118 0.5× 83 3.0k
Vassilis Zoumpourlis Greece 27 1.4k 0.7× 549 0.5× 428 0.7× 174 0.7× 262 1.1× 76 2.4k
Razmik Mirzayans Canada 27 1.8k 0.8× 835 0.8× 666 1.2× 167 0.7× 245 1.1× 82 2.5k
Insoo Bae United States 32 2.5k 1.1× 1.4k 1.4× 688 1.2× 293 1.2× 259 1.1× 61 3.5k
Annie Dutriaux France 14 2.4k 1.1× 1.6k 1.6× 489 0.9× 300 1.3× 497 2.2× 25 3.1k
Isabella Manni Italy 25 1.9k 0.8× 785 0.8× 494 0.9× 171 0.7× 218 0.9× 57 2.5k
Rieko Ohki Japan 21 2.3k 1.1× 1.2k 1.2× 445 0.8× 194 0.8× 216 0.9× 50 3.0k
Baiqu Huang China 37 3.1k 1.4× 620 0.6× 1.1k 1.9× 222 0.9× 185 0.8× 107 4.0k
So Hee Kwon South Korea 26 2.3k 1.1× 594 0.6× 393 0.7× 142 0.6× 153 0.7× 80 2.9k

Countries citing papers authored by Sagar Sengupta

Since Specialization
Citations

This map shows the geographic impact of Sagar Sengupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sagar Sengupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sagar Sengupta more than expected).

Fields of papers citing papers by Sagar Sengupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sagar Sengupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sagar Sengupta. The network helps show where Sagar Sengupta may publish in the future.

Co-authorship network of co-authors of Sagar Sengupta

This figure shows the co-authorship network connecting the top 25 collaborators of Sagar Sengupta. A scholar is included among the top collaborators of Sagar Sengupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sagar Sengupta. Sagar Sengupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sengupta, Sagar, et al.. (2025). p53 regulates DREAM complex-mediated repression in a p21-independent manner. The EMBO Journal. 44(8). 2279–2297. 1 indexed citations
2.
Yadav, Poonam, Viviani Nardini, Ruchira Chakraborty, et al.. (2024). Engineered nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression. Journal of Controlled Release. 368. 548–565. 5 indexed citations
3.
Kaur, Ekjot, et al.. (2024). Regulation of pathway choice in DNA repair after double-strand breaks. Current Opinion in Pharmacology. 80. 102496–102496. 10 indexed citations
4.
Hussain, Mansoor, et al.. (2023). Hyperubiquitylation of DNA helicase RECQL4 by E3 ligase MITOL prevents mitochondrial entry and potentiates mitophagy. Journal of Biological Chemistry. 299(9). 105087–105087. 4 indexed citations
5.
Kaur, Ekjot, et al.. (2021). Functions of BLM Helicase in Cells: Is It Acting Like a Double-Edged Sword?. Frontiers in Genetics. 12. 634789–634789. 46 indexed citations
6.
Hussain, Mansoor, et al.. (2021). MITOL-dependent ubiquitylation negatively regulates the entry of PolγA into mitochondria. PLoS Biology. 19(3). e3001139–e3001139. 15 indexed citations
7.
Sreekanth, Vedagopuram, Sandeep Kumar, Sanjay Pal, et al.. (2020). Bile Acid Tethered Docetaxel‐Based Nanomicelles Mitigate Tumor Progression through Epigenetic Changes. Angewandte Chemie International Edition. 60(10). 5394–5399. 17 indexed citations
8.
Tripathi, Vivek, et al.. (2019). Abrogation of FBW7α-dependent p53 degradation enhances p53’s function as a tumor suppressor. Journal of Biological Chemistry. 294(36). 13224–13232. 24 indexed citations
9.
Tripathi, Vivek, et al.. (2018). MRN complex-dependent recruitment of ubiquitylated BLM helicase to DSBs negatively regulates DNA repair pathways. Nature Communications. 9(1). 1016–1016. 58 indexed citations
10.
Gupta, Shruti, Vivek Srivastava, Mansoor Hussain, et al.. (2013). RECQL4 and p53 potentiate the activity of polymerase γ and maintain the integrity of the human mitochondrial genome. Carcinogenesis. 35(1). 34–45. 53 indexed citations
11.
Tikoo, Shweta, et al.. (2013). Enhancement of c-Myc degradation by Bloom (BLM) helicase leads to delayed tumor initiation. Journal of Cell Science. 126(Pt 16). 3782–95. 21 indexed citations
12.
Sengupta, Sagar, et al.. (2012). Inositol Pyrophosphate Synthesis by Inositol Hexakisphosphate Kinase 1 Is Required for Homologous Recombination Repair. Journal of Biological Chemistry. 288(5). 3312–3321. 43 indexed citations
13.
Srivastava, Vivek, et al.. (2010). Chk1-Dependent Constitutive Phosphorylation of BLM Helicase at Serine 646 Decreases after DNA Damage. Molecular Cancer Research. 8(9). 1234–1247. 24 indexed citations
14.
Zhang, Ran, Sagar Sengupta, Qin Yang, et al.. (2005). BLM Helicase Facilitates Mus81 Endonuclease Activity in Human Cells. Cancer Research. 65(7). 2526–2531. 43 indexed citations
15.
Sengupta, Sagar & Curtis C. Harris. (2005). p53: traffic cop at the crossroads of DNA repair and recombination. Nature Reviews Molecular Cell Biology. 6(1). 44–55. 417 indexed citations
16.
Yang, Qin, Ran Zhang, Xin Wei Wang, et al.. (2004). The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase. Oncogene. 23(21). 3749–3756. 62 indexed citations
17.
Sengupta, Sagar & Bohdan Wasylyk. (2004). Physiological and Pathological Consequences of the Interactions of the p53 Tumor Suppressor with the Glucocorticoid, Androgen, and Estrogen Receptors. Annals of the New York Academy of Sciences. 1024(1). 54–71. 70 indexed citations
18.
Sengupta, Sagar & Bohdan Wasylyk. (2001). Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes & Development. 15(18). 2367–2380. 112 indexed citations
19.
Sengupta, Sagar, Ranju Ralhan, & Bohdan Wasylyk. (2000). Tumour regression in a ligand inducible manner mediated by a chimeric tumour suppressor derived from p53. Oncogene. 19(3). 337–350. 6 indexed citations
20.
Sengupta, Sagar, M.S. Shaila, & G. Ramananda Rao. (1997). In vitro and in vivo regulation of assimilatory nitrite reductase from Candida utilis. Archives of Microbiology. 168(3). 215–224. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026